Improving medication adherence in children with eosinophilic esophagitis
Innovations in treatment adherence in pediatric eosinophilic esophagitis
This study is all about helping teenagers with eosinophilic esophagitis stick to their medication routines better by creating a helpful plan, and it will also look at how a specific medication called dupilumab affects their ability to follow these routines and their overall health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-11168887 on NIH RePORTER |
What this research studies
This research focuses on enhancing medication adherence among adolescents with eosinophilic esophagitis, a chronic inflammatory condition of the esophagus. The approach involves developing a Medication Habit Action Plan (MHAP) that helps patients build better habits around their medication routines. The study will include usability testing with patients and healthcare providers, followed by a pilot trial to assess the feasibility of the MHAP. Additionally, it will evaluate the impact of the medication dupilumab on adherence and clinical outcomes in these patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents diagnosed with eosinophilic esophagitis who struggle with medication adherence.
Not a fit: Patients without eosinophilic esophagitis or those who do not have issues with medication adherence may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve medication adherence and health outcomes for adolescents with eosinophilic esophagitis.
How similar studies have performed: Previous research has shown that behavior change interventions can effectively improve medication adherence, suggesting a promising avenue for this approach.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Mehta, Pooja — University of Colorado Denver
- Study coordinator: Mehta, Pooja
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.